Publications by authors named "Frederick Millard"

Claim this Profile
O
Osteoporosis Amongst Testicular Cancer Survivors: Long Term Follow-Up of the Veterans Affairs Health System.
Nuphat Yodkhunnatham, Paul Riviere, Kshitij Pandit, Kylie Morgan, Margaret Meagher, Frederick Millard

Clin Genitourin Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of subcentimeter pulmonary nodules in clinical stage I seminoma patients.
Nuphat Yodkhunnatham, Dhruv Puri, Kshitij Pandit, Austin Leonard, Isabella Dolendo, Frederick E Millard

Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Syndrome Among Testicular Cancer Survivors: Long-Term Follow-Up of the Veterans Affairs Health System.
Dhruv Puri, Paul Riviere, Margaret Meagher, Kylie Morgan, Tyler Nelson, Frederick Millard

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of benign prostatic hyperplasia in testicular cancer survivors in the Veteran's affairs health system.
Kshitij Pandit, Kylie Morgan, Paul Riviere, Margaret Meagher, Mai Dabbas, Frederick Millard

World J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
Kshitij Pandit, Paul Riviere, Kylie Morgan, Tyler Nelson, Margaret Meagher, Frederick Millard

J Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Long-term Quality of Life of Testicular Cancer Survivors Differs According to Applied Adjuvant Treatment and Tumour Type.
Richard S Matulewicz, Nirmish Singla, Kshitij Pandit, Frederick Millard, Aditya Bagrodia

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver mutations associated with signatures of platinum sensitivity in germ cell tumors.
Yun Cheng Sawa, Liwei Jia, Harris Krause, Margaret Meagher, Frederick Millard

NPJ Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual Follow-Up in Patients Initiating Antineoplastic Treatment in the Ambulatory Setting.
Lauren J Chew, Danielle S Urman, Kevin Maxwell, Archana Ajmera, Frederick Millard

JCO Oncol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed therapy in testicular cancer.
Kshitij Pandit, Kit Yuen, Dhruv Puri, Nuphat Yodkhunnatham, Frederick Millard

Curr Opin Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and Management of Testicular Cancer After Late Relapse.
Joanna L Langner, Frederick Millard, Vera Vavinskaya, Haiyan Zhang, Nuphat Yodkhunnatham

Oncology (Williston Park)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.
Aaron M Lee, Ava Saidian, Justin Shaya, Taylor Nonato, Angelo Cabal, Frederick Millard

Clin Genitourin Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline alterations among Hispanic men with prostate cancer.
Elizabeth Pan, Justin Shaya, Lisa Madlensky, J Michael Randall, Juan Javier-Desloges, Frederick E Millard

Prostate Cancer Prostatic Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Germline alterations among Hispanic men with prostate cancer.
Elizabeth Pan, Justin Shaya, Lisa Madlensky, J Michael Randall, Juan Javier-Desloges, Frederick E Millard

Prostate Cancer Prostatic Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Prognostic Significance of Circulating Tumor DNA in Metastatic Castrate Resistant Prostate Cancer.
Justin Shaya, Taylor Nonato, Angelo Cabal, James Michael Randall, Frederick Millard

Clin Genitourin Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, Lauren Harshman, Leonard Appleman, Frederick Millard

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.
Charles A Field, Brittney H Cotta, Juan Jimenez, Brian R Lane, Kendrick Yim, Frederick E Millard

Clin Genitourin Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis.
Michelle L McDonald, Brian R Lane, Juan Jimenez, Hak J Lee, Kendrick Yim, Frederick Millard

Clin Genitourin Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy for localized and locally advanced renal cell carcinoma.
Ahmet Bindayi, Zachary A Hamilton, Michelle L McDonald, Kendrick Yim, Frederick Millard

Urol Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Peter F Coccia, Alberto S Pappo, Lynda Beaupin, Virginia F Borges, Scott C Borinstein, Frederick Millard

J Natl Compr Canc Netw· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial.
Emmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, Lawrence I Karsh, Aymen Elfiky, Frederick E Millard

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma.
Zachary Hamilton, Hak J Lee, Juan Jimenez, Brian R Lane, Song Wang, Frederick Millard

BJU Int· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.
Nishant Patel, Jason Woo, Michael A Liss, Kerrin L Palazzi, J Michael Randall, Frederick Millard

Can J Urol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?
Hossein S Mirheydar, Pooya Banapour, Rustin Massoudi, Kerrin L Palazzi, Ramzi Jabaji, Frederick E Millard

Int Braz J Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.
J Michael Randall, Frederick Millard, Razelle Kurzrock

Cancer Metastasis Rev· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.
Matthew I Milowsky, Christian Dittrich, Ignacio Durán, Satinder Jagdev, Frederick E Millard

Eur J Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis